CTOs on the Move

Orexigen

www.orexigen.com

 
Orexigen`s commitment to patients is reflected in all that we do: we are a company driven by the knowledge that our work is important and the desire to make a difference. Orexigen offers prospective employees exciting challenges` unique opportunities for career growth` and a fast-paced environment that emphasizes innovation and achievement.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.orexigen.com
  • 3344 N. Torrey Pines Court Suite 200
    La Jolla, CA USA 92037
  • Phone: 858.875.8600

Executives

Name Title Contact Details

Funding

Orexigen raised $60M on 09/14/2015

Similar Companies

Found

Found is a modern weight care platform pioneering integrated support through personalized coaching, online community, and if indicated, prescription medication. We believe that weight care is complex and goes beyond having the willpower to eat less and move more. We believe in the power of biology, genetics, sleep, stress, mental health and daily habits and we work with each factor to achieve long-lasting results. Our goals are to address the long-term risks associated with ineffective weight management, to reimagine the narrow and outdated cultural narrative around weight, and to empower our community with tools that will help them find self-acceptance and add years to their lives. We believe it`s not just what you`ve lost, it`s what you`ve Found.

IC Sciences Corporation

IC Sciences Corporation is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Surgicount Medical

Surgicount Medical is a Temecula, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Plasmatech Biopharmaceuticals

Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.

Brill

Brill is a Delray Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.